Transdermals: from Patches to Profits.
The transdermal drug delivery system market is booming, with a huge leap from a market value of $5.7bn USD just three years ago, to its current forecast of reaching $7.1 billion by 2023.
Showing a compound annual growth rate of 4.5% over the 5 year period, the patch sector in particular is set to be the best performer overall. The portfolio of benefits it brings, including being non-invasive, improved bioavailability, reduced dosing frequency and adverse events, combined with specialized treatments for central nervous system disorders, hormonal applications and cardiovascular diseases mean there’s possibility that the growth could be even stronger than predicted.
North America is expected to continue dominating the market, as it has for the past multiple years. Driven by technological advancements in transdermal drug delivery systems, and the growth of specialist development and manufacturing companies such as Greene Street Pharmaceuticals, the adoption of this skin permeation system is gaining astounding new notoriety.
Find out more about transdermals and our unique systems by getting in touch with us today.
April 8, 2021